8K7 — UG Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- SG$68.62m
- SG$51.33m
- SG$101.13m
- 18
- 54
- 64
- 40
Annual cashflow statement for UG Healthcare, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.76 | 18.1 | 159 | 48.8 | -28.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.887 | 0.089 | 1.25 | 4.96 | -13.4 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.87 | -9.62 | -82.5 | -3.68 | -3.01 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.37 | 11 | 81.2 | 54 | -41.3 |
| Capital Expenditures | -8.6 | -3.29 | -19.7 | -22.3 | -8.03 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.71 | 0.441 | 0.809 | 1.13 | 2.15 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.89 | -2.85 | -18.9 | -21.2 | -5.88 |
| Financing Cash Flow Items | — | — | — | — | 0.041 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.4 | -3.74 | -3.14 | -0.973 | 8.74 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.86 | 4.4 | 59.1 | 31.8 | -38.4 |